Altria Options Turn Defensive as Q3 Print Looms

Altria Group reports Q3 results on October 29 with options positioning growing more cautious just as the stock comes off a bruising prior quarter.

The clearest shift heading into the print is in the options market. The put/call ratio has moved to 0.81, above its 20-day average of 0.75, a level that has crept higher over the past two weeks as the earnings date approached. That is still well below the panic readings above 1.20 seen in mid-September, but the direction of travel is notable: the PCR sat near its 52-week low of 0.63 in early October and has risen since. The stock itself dropped 2.3% on October 23 alone, pulling the one-week return to minus 1.1%. That is actually a relatively resilient outcome: the closest peer group posted a median decline of around 2.1% over the same period, with PM off 2.8% and UVV down 3.4%. The borrow market carries no meaningful pressure; availability is extremely loose at over 5,600% of short interest, and cost to borrow sits at 0.55%, barely changed over the past month.

Short interest tells an unexciting story. At 2.3% of the free float, it is low by any standard. The level has crept up roughly 0.5% over the past week but has fallen around 4% over the past month. There is no short squeeze risk, no squeeze pressure, and no sign that money is building a material bearish position in the lending market.

The sharper tension is in the analyst debate. The stock has rallied roughly 28% in 2026, and at $74.31 it now trades above most published price targets: the consensus mean sits at $70.00 as of August, with Barclays holding an Underweight and a $58 target while UBS argues for a Buy with a $79 target. That spread captures the genuine disagreement. The bull case rests on Marlboro's 42% cigarette market share and the On! oral tobacco brand reaching an 8.8% retail share, up 180 basis points year on year, a category that carries better long-term optics than combustibles. The bear case points to fewer than 15% of adults aged 18 and over now reporting recent cigarette use, a structural demand decline that legacy smokeless brands have not fully offset. Forward EPS growth ranks in the 75th percentile of the market, and the earnings yield factor scores at the 63rd percentile, so the valuation is not obviously stretched on a cash-flow basis. The price-to-book is deeply negative, reflecting years of buybacks and leveraged capital returns rather than balance sheet weakness, but it complicates simple valuation comparisons. The dividend factor scores at the 99th percentile, the primary reason income-oriented institutions have stayed committed: BlackRock and Vanguard entities together hold over 14% of shares outstanding, and Capital Research added over 33 million shares in the most recent quarter.

One data point outside the usual metrics is worth flagging. Wikipedia traffic for Altria is running well above its own 90-day norm, with a z-score of 2.6 as of October 21, the highest retail attention reading in recent months. This is an attention signal, not a revenue indicator, but spikes like this around earnings tend to coincide with periods when retail holders are reassessing a position rather than holding passively.

The Q3 report will test whether the On! volume trajectory is strong enough to offset continued combustible volume declines and whether management can sustain margin guidance in a market where both categories face pressure. The prior quarter's 8.8% drop on the day following results set a high bar for downside surprise; the stock's outperformance against peers this year sets an equally high bar for the upside.